Patients with joint conditions such as osteoarthritis (OA) could see pain levels reduced by a new brand of rose-hip powder, according to research.
Rose-hip powder containing the active ingredient GOPO (glycoside of mono and diglycerol) has been found to reduce joint pain and stiffness in people with OA.
The findings could reduce patients' consumption of potentially dangerous pain-relieving medications, and improve their overall mood, energy and sleep quality, the Osteoarthritis Research Society International (OARSI) World Congress of Osteoarthritis in Rome heard.
The latest studies attempted to explain how GOPO exerts its beneficial effects on joint health and highlighted the compound's ability to protect, or even potentially regenerate, joint tissues.
Researcher Dr Kaj Winther, from the Frederiksberg Hospital at the University of Copenhagen in Denmark, said: "We have little doubt that certain rose-hip preparations, and GOPO in particular, have an important role to play in reducing the pain and disability associated with some joint conditions.
"We were pleased with the level of interest our new research generated and suspect that more people will be turning to the power of rose-hip for joint pain relief."
Only one proprietary brand of rose-hip powder containing GOPO - LitoZin - is currently available in the UK.